MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.85
+0.26 (3.43%)
Apr 20, 2026, 4:08 PM HKT

HKG:2235 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
660.79340.35248.35169.89151.4
Other Revenue
-5.264.883.72-
660.79345.62253.23173.61151.4
Revenue Growth (YoY)
91.19%36.48%45.86%14.67%101.13%
Cost of Revenue
303.36166.54136.0893.9180.52
Gross Profit
357.42179.08117.1479.6970.88
Selling, General & Admin
271.34249.28250.62158.2393.74
Research & Development
76.3476.5670.161.0936.08
Other Operating Expenses
-9.61-0.79-9.28-21.99-
Operating Expenses
339.61326.49312.43200.04131.05
Operating Income
17.82-147.41-195.29-120.34-60.17
Interest Expense
-0.13-0.68-0.05-0.15-0.02
Interest & Investment Income
53.964.2568.2455.7224.49
Currency Exchange Gain (Loss)
-9.77.1129.95-16.48
Other Non Operating Income (Expenses)
-22.04-0.3-4.68-0.223.97
EBT Excluding Unusual Items
49.55-74.44-124.67-35.03-48.2
Gain (Loss) on Sale of Investments
-0.030.09-0.02--
Gain (Loss) on Sale of Assets
0.01---0.010.05
Asset Writedown
-9.12-0.83-0.16-0-
Other Unusual Items
-12.030--
Pretax Income
40.4-63.15-124.85-35.04-48.15
Income Tax Expense
0.25-0.030.160-
Earnings From Continuing Operations
40.15-63.12-125.02-35.04-48.15
Net Income
40.15-63.12-125.02-35.04-48.15
Net Income to Common
40.15-63.12-125.02-35.04-48.15
Shares Outstanding (Basic)
402418431438373
Shares Outstanding (Diluted)
402418431438373
Shares Change (YoY)
-3.93%-3.05%-1.59%17.39%21.79%
EPS (Basic)
0.10-0.15-0.29-0.08-0.13
EPS (Diluted)
0.10-0.15-0.29-0.08-0.13
Free Cash Flow
--120.65-153-148.79-61.82
Free Cash Flow Per Share
--0.29-0.35-0.34-0.17
Gross Margin
54.09%51.81%46.26%45.91%46.82%
Operating Margin
2.70%-42.65%-77.12%-69.32%-39.74%
Profit Margin
6.08%-18.26%-49.37%-20.18%-31.80%
Free Cash Flow Margin
--34.91%-60.42%-85.71%-40.83%
EBITDA
29.02-136.21-184.12-110.19-52.28
EBITDA Margin
4.39%-39.41%-72.71%-63.47%-34.53%
D&A For EBITDA
11.211.211.1710.157.88
EBIT
17.82-147.41-195.29-120.34-60.17
EBIT Margin
2.70%-42.65%-77.12%-69.32%-39.74%
Effective Tax Rate
0.62%----
Revenue as Reported
-345.62253.23173.61-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.